Abstract
Background:
Melasma is a cutaneous pigmentary condition, difficult to treat due to its multifactorial chronic nature and high recurrence rates.
Objective:
To investigate the medium-term and long-term efficacy of the 675 nm laser for the treatment of facial melasma with pigmentary and vascular symptoms.
Methods:
Eight patients with facial melasma and Fitzpatrick phototypes III to IV were recruited. Three sessions were carried out with a 675-nm laser device. At 5 months and 12 months after the last treatment, the patient’s skin was evaluated from baseline using a five-point Global Aesthetic Improvement Scale (GAIS).
Results:
The study findings revealed a better overall appearance of the skin condition, in particular GAIS improvements mainly in the visible and pigmented components.
Conclusion:
The 675-nm laser appears to be effective when treating patients with Fitzpatrick phototypes III to IV for facial melasma, with promising long-term results.
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
